The Milwaukee Brewers weren't planning for this series to go five games, but they were still prepared for it. In Game 5, it was a clash of bullpen games, with Milwaukee holding the advantage. Rookies ...

Matthew Boyd pitched two-hit ball into the fifth inning, and the Chicago Cubs shut down the Milwaukee Brewers for a 6-0 victory Thursday night that pushed their NL Division Series all the way to a ...

The Elder Scrolls Elder Scrolls MMO lead still wants to make a new game, despite the cancelation of the Blackbird project that Xbox's Phil Spencer apparently loved: "I don't think you can ride one ...

DUBAI, Oct 6 (Reuters) - Blackstone (BX.N), opens new tab and Abu Dhabi's Lunate plan to set up a platform that will target investments in logistics assets in the Gulf region worth $5 billion, the two ...

This is important because: Microsoft is closing the side doors to offline setup. As familiar workarounds disappear, most people are guided toward a Microsoft account on day one, which narrows choice ...

TheStreet aims to feature only the best products and services. If you buy something via one of our links, we may earn a commission. The MF Studio 4-Piece Patio Set is available for just $663 at the ...

Magic: The Gathering has a busy 2026 planned, but one set remained a mystery up until now... a crossover with Nickelodeon. Not only is that set now revealed to star none other than the Teenage Mutant ...

Novo Nordisk, the Danish drug manufacturer behind the weight-loss and diabetes drug Ozempic and other medications, said it’s paying up to $5.2 billion to buy Akero Therapeutics, a biotech company with ...

The YouTube family of apps have their own design language, and the latest change is an updated icon set that is widely rolling out to YouTube Music. Update 10/23: Last week, YouTube officially ...

Mastering push-ups and pull-ups requires progressing from building strength to developing muscular endurance. Conquering your first repetition of these calisthenics exercises is a matter of strength, ...

Novo NordiskNVO said Thursday it will pay up to $5.2 billion to acquire Akero TherapeuticsAKRO for its experimental liver disease treatment. Akero stock catapulted 16.3%, closing at 54.08, while Novo ...

Accelerate your tech game Paid Content How the New Space Race Will Drive Innovation How the metaverse will change the future of work and society Managing the ...